BETA


2018/0118(NLE) Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures

Progress: Awaiting final decision

RoleCommitteeRapporteurShadows
Lead LIBE ŠKRIPEK Branislav (icon: ECR ECR) HORTEFEUX Brice (icon: PPE PPE), HEDH Anna (icon: S&D S&D), PAGAZAURTUNDÚA Maite (icon: ALDE ALDE), ANDERSON Martina (icon: GUE/NGL GUE/NGL)
Lead committee dossier:

Events

2018/09/11
   EP - Results of vote in Parliament
2018/09/11
   EP - Decision by Parliament, 1st reading/single reading
Details

The European Parliament adopted by 635 votes to 11, with 37 abstentions, following the consultation procedure, a legislative resolution on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

Parliament approved the Council draft which aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

Documents
2018/09/03
   EP - Committee report tabled for plenary, 1st reading/single reading
Details

The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Branislav ŠKRIPEK (ECR, SK) on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

The committee recommended that Parliament approve the Council draft .

The risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

Documents
2018/08/30
   EP - Vote in committee, 1st reading/single reading
2018/07/02
   EP - Committee referral announced in Parliament, 1st reading/single reading
2018/06/21
   EP - Committee draft report
Documents
2018/06/20
   EP - ŠKRIPEK Branislav (ECR) appointed as rapporteur in LIBE
2018/06/11
   EC - Legislative proposal published
Details

PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

PROPOSED ACT: Council Implementing Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

CONTENT: the draft Council implementing decision aims to subject the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide ('cyclopropylfentanyl') and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide ('methoxyacetylfentanyl') to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

Documents
2018/04/30
   EC - Initial legislative proposal published
Details

PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

PROPOSED ACT: Council Implementing Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

Documents

Votes

A8-0271/2018 - Branislav Škripek - Vote unique 11/09/2018 12:43:06.000

2018/09/11 Outcome: +: 635, 0: 37, -: 11
DE FR IT ES PL GB RO CZ BE HU PT AT SE NL EL BG SK FI DK HR LT SI EE IE CY MT LU LV ??
Total
85
65
64
50
51
67
28
21
20
20
18
18
18
25
17
15
13
12
11
10
9
8
6
8
6
6
5
5
2
icon: PPE PPE
202

United Kingdom PPE

2

Finland PPE

2

Denmark PPE

For (1)

1

Estonia PPE

For (1)

1

Cyprus PPE

1

Luxembourg PPE

2
icon: S&D S&D
172

Netherlands S&D

For (2)

2

Croatia S&D

2

Lithuania S&D

1

Slovenia S&D

For (1)

1

Estonia S&D

For (1)

1

Ireland S&D

For (1)

1

Cyprus S&D

2

Malta S&D

3

Luxembourg S&D

For (1)

1

Latvia S&D

1
icon: ALDE ALDE
64

Germany ALDE

3

United Kingdom ALDE

1

Romania ALDE

3

Portugal ALDE

1

Austria ALDE

For (1)

1

Sweden ALDE

2

Denmark ALDE

2

Croatia ALDE

2

Slovenia ALDE

For (1)

1

Estonia ALDE

3

Ireland ALDE

For (1)

1

Luxembourg ALDE

For (1)

1

Latvia ALDE

1
icon: ECR ECR
70

Italy ECR

2

Romania ECR

2

Czechia ECR

2

Sweden ECR

2

Netherlands ECR

2

Greece ECR

For (1)

1

Bulgaria ECR

2
2

Croatia ECR

For (1)

1

Lithuania ECR

1

Cyprus ECR

1
icon: Verts/ALE Verts/ALE
45

France Verts/ALE

4

Italy Verts/ALE

For (1)

1

Spain Verts/ALE

2

United Kingdom Verts/ALE

5

Belgium Verts/ALE

2

Hungary Verts/ALE

2

Austria Verts/ALE

3

Netherlands Verts/ALE

2

Finland Verts/ALE

For (1)

1

Denmark Verts/ALE

For (1)

1

Croatia Verts/ALE

For (1)

1

Lithuania Verts/ALE

For (1)

1

Slovenia Verts/ALE

For (1)

1

Estonia Verts/ALE

For (1)

1

Luxembourg Verts/ALE

For (1)

1
icon: GUE/NGL GUE/NGL
43

Italy GUE/NGL

2

United Kingdom GUE/NGL

1

Sweden GUE/NGL

For (1)

1

Netherlands GUE/NGL

3

Finland GUE/NGL

For (1)

1

Denmark GUE/NGL

For (1)

1

Ireland GUE/NGL

For (1)

Against (1)

2

Cyprus GUE/NGL

2
icon: ENF ENF
31

Germany ENF

Abstain (1)

1

Poland ENF

2

Belgium ENF

For (1)

1

Netherlands ENF

4
icon: EFDD EFDD
37

Germany EFDD

Abstain (1)

1

Poland EFDD

1

Czechia EFDD

Abstain (1)

1

EFDD

Abstain (1)

1
icon: NI NI
19

Germany NI

Against (1)

2

France NI

For (1)

1

United Kingdom NI

Against (1)

4

NI

For (1)

1

History

(these mark the time of scraping, not the official date of the change)

committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2018-06-20T00:00:00
rapporteur
name: ŠKRIPEK Branislav group: European Conservatives and Reformists abbr: ECR
shadows
events/5
date
2018-09-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=31453&l=en title: Results of vote in Parliament
activities
  • date: 2018-04-30T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2018/0253/COM_COM(2018)0253_EN.pdf title: COM(2018)0253 type: Initial legislative proposal published celexid: CELEX:52018PC0253:EN body: EC commission: DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Initial legislative proposal published
  • date: 2018-06-11T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 09420/2018 body: EC commission: DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Legislative proposal published
  • date: 2018-07-02T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
  • date: 2018-08-30T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
  • body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0271/2018 type: Committee report tabled for plenary, 1st reading/single reading committees: body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav date: 2018-09-03T00:00:00
  • date: 2018-09-11T00:00:00 body: EP type: Vote in plenary scheduled
commission
  • body: EC dg: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2018-06-20T00:00:00
rapporteur
name: ŠKRIPEK Branislav group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
body
EP
shadows
responsible
True
committee
LIBE
date
2018-06-20T00:00:00
committee_full
Civil Liberties, Justice and Home Affairs
rapporteur
group: ECR name: ŠKRIPEK Branislav
docs
  • date: 2018-06-21T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813 title: PE623.813 type: Committee draft report body: EP
events
  • date: 2018-04-30T00:00:00 type: Initial legislative proposal published body: EC docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2018/0253/COM_COM(2018)0253_EN.pdf title: COM(2018)0253 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2018&nu_doc=0253 title: EUR-Lex summary: PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. PROPOSED ACT: Council Implementing Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018. They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals. Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed. Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed. Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays. The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union. CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
  • date: 2018-06-11T00:00:00 type: Legislative proposal published body: EC docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 09420/2018 summary: PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. PROPOSED ACT: Council Implementing Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018. They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals. Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed. Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed. Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays. The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union. CONTENT: the draft Council implementing decision aims to subject the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide ('cyclopropylfentanyl') and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide ('methoxyacetylfentanyl') to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
  • date: 2018-07-02T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2018-08-30T00:00:00 type: Vote in committee, 1st reading/single reading body: EP
  • date: 2018-09-03T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN title: A8-0271/2018 summary: The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Branislav ŠKRIPEK (ECR, SK) on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. The committee recommended that Parliament approve the Council draft . The risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018. The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.
  • date: 2018-09-11T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2018-0320 title: T8-0320/2018 summary: The European Parliament adopted by 635 votes to 11, with 37 abstentions, following the consultation procedure, a legislative resolution on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. Parliament approved the Council draft which aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
links
other
  • body: EC dg: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure/Modified legal basis
Old
Rules of Procedure EP 150
New
Rules of Procedure EP 159
procedure/dossier_of_the_committee
Old
LIBE/8/13013
New
  • LIBE/8/13013
procedure/instrument
Decision
procedure/stage_reached
Old
Awaiting Parliament 1st reading / single reading / budget 1st stage
New
Awaiting final decision
procedure/subject
Old
  • 7.30.30.04 Action to combat drugs and drug-trafficking
New
7.30.30.04
Action to combat drugs and drug-trafficking
activities/0/docs/0/text
  • PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

    PROPOSED ACT: Council Implementing Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

    They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

    Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

    Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

    Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

    The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

    CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

activities/0/docs/0/type
Old
Legislative proposal published
New
Initial legislative proposal published
activities/0/type
Old
Legislative proposal published
New
Initial legislative proposal published
activities/1
date
2018-06-11T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 09420/2018
type
Legislative proposal published
body
EC
commission
DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
activities/2
date
2018-07-02T00:00:00
body
EP
type
Committee referral announced in Parliament, 1st reading/single reading
committees
body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
activities/3
date
2018-08-30T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
activities/4
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0271/2018
type
Committee report tabled for plenary, 1st reading/single reading
committees
body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
date
2018-09-03T00:00:00
activities/5
date
2018-09-11T00:00:00
body
EP
type
Vote in plenary scheduled
committees/0/date
2018-06-20T00:00:00
committees/0/rapporteur
  • group: ECR name: ŠKRIPEK Branislav
committees/0/shadows
  • group: EPP name: HORTEFEUX Brice
  • group: S&D name: HEDH Anna
  • group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite
  • group: GUE/NGL name: ANDERSON Martina
procedure/Modified legal basis
Rules of Procedure EP 150
procedure/dossier_of_the_committee
LIBE/8/13013
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
activities
  • date: 2018-04-30T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2018/0253/COM_COM(2018)0253_EN.pdf celexid: CELEX:52018PC0253:EN type: Legislative proposal published title: COM(2018)0253 type: Legislative proposal published body: EC commission: DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
committees
  • body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
links
other
  • body: EC dg: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure
reference
2018/0118(NLE)
title
Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures
stage_reached
Preparatory phase in Parliament
subtype
Consultation of Parliament
type
NLE - Non-legislative enactments
subject
7.30.30.04 Action to combat drugs and drug-trafficking